JLK-SDH

by JLK, Inc.  · Based in South Korea → — A New Paradigm in Stroke Workflow: Applying innovative AI-based data analysis technology to stroke.
Emergency Medicine Neurosurgery Radiology

Regulatory Status Disclosed

Overview

JLK Inc. is a South Korea-based medical AI company founded in 2014, specializing in advanced AI solutions for medical image analysis. The company primarily focuses on neurological diseases, including various types of stroke (hemorrhage, infarction, aneurysm), and a range of cancers (prostate, breast, lung, thyroid). JLK’s portfolio includes AI-powered diagnostic and triage tools that analyze medical images such as CT, MRI, X-ray, and mammography. These solutions are designed to enhance the speed and accuracy of diagnosis, streamline treatment workflows, and ultimately improve patient outcomes by providing critical AI-driven insights to medical professionals. JLK also offers an integrated platform, JLK-AILink, and a mobile application for real-time notifications.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered subdural hemorrhage (SDH) detection
  • Analyzes non-contrast CT scans for SDH
  • Aims to analyze scans 30% faster than standard methods
  • Provides triage and notification prioritization for suspected SDH
  • Mobile app integration for real-time notifications (e.g., SNAPPY)
  • Adheres to DICOM standard for image communication
  • Integrates with hospital PACS systems
  • Supports image manipulation and annotation tools (via JLK-AILink platform)
  • Part of an integrated AI-powered medical imaging platform (JLK-AILink)
  • Aids emergency physicians in rapid decision-making for stroke patients

Use Cases

  • Rapid detection and triage of subdural hemorrhage in emergency settings
  • Assisting emergency physicians in diagnosing SDH from CT scans
  • Improving workflow efficiency in hospital emergency departments
  • Supporting clinical assessment and informed decisions in stroke management
  • Prioritizing patient cases with suspected intracranial hemorrhage

What Physicians Need to Know

Stroke Detection Speed
JLK-SDH analyzes CT scans 30% faster than standard methods for subdural hemorrhage (SDH) detection.
Brain MRI/CT Analysis
JLK-SDH is an AI-powered tool for detecting subdural hemorrhage (SDH) on non-contrast CT scans. JLK's broader MEDIHUB STROKE solution offers multi-modality medical imaging analysis including CT, CTA, CTP, MRI, and MRA, covering all types of stroke (hemorrhage and ischemia).
Large Vessel Occlusion Detection
JLK-LVO, another JLK product, is a deep learning-based AI tool for automated large vessel occlusion (LVO) detection on CT angiography (CTA). It has demonstrated high overall performance with an AUROC of 0.93 and a sensitivity of 0.890 and specificity of 0.965 for LVO detection in patients with symptom onset within 24 hours.
Triage Prioritization Speed
JLK-SDH aims to be a critical tool in triage and decision-making for head trauma patients in emergency rooms.
ASPECTS Score Automation
While not specifically mentioned for JLK-SDH, JLK's stroke platform includes various AI-based tools for stroke analysis. Automated ASPECTS scoring tools exist to quantify early ischemic changes on non-contrast CT to support treatment decisions in acute ischemic stroke.
Mobile Notification System
JLK-SDH is integrated into FASTRO (formerly SNAPPY), a mobile app that alerts physicians when SDH is detected on non-contrast CT scans.
Physician Tip

JLK-SDH can significantly reduce the time to detect subdural hemorrhage, which is crucial in emergency settings. The integration with the FASTRO mobile app allows for rapid physician notification, potentially improving patient outcomes by enabling faster intervention. Consider integrating JLK-SDH into your emergency workflow for head trauma cases to leverage its speed and accuracy in SDH detection. For comprehensive stroke assessment, explore JLK's broader MEDIHUB STROKE solution, which covers various stroke types and imaging modalities.

JLK-SDH is part of JLK's integrated AI-powered medical imaging platform, JLK-AILink, which integrates stroke diagnostics across CT, CTA, CTP, and MRI. The company is focused on providing an integrated approach to cut hospital maintenance costs. JLK has also launched FASTRO, an integrated mobile medical app. JLK is developing an LLM-based platform, JOOMED, that integrates and analyzes medical images with clinical information like EMRs, test results, and radiology reports.

Details

Category Neurology AI
Pricing Unknown
DeploymentJLK servers
Mobile App1
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Emergency Medicine, Neurosurgery, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-03-03K243611 510(k)JLK-SDH

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate JLK-SDH

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for JLK-SDH.

No videos found. Search YouTube directly

View all on YouTube

Frequently Asked Questions

JLK-SDH is an AI-powered tool designed to detect and quantify subdural hematomas (SDH) from non-contrast head CT scans. It helps physicians by analyzing scans, identifying the presence of SDH, and providing measurements for thickness, volume, and midline shift, potentially leading to faster diagnosis and treatment in emergency settings.
In an independent validation study, JLK-SDH demonstrated a sensitivity of 91.4%, specificity of 96.4%, and overall accuracy of 95.1% for detecting SDH. For SDH thicker than 10 mm, the sensitivity was 100%. The model also achieved 85.33% prediction accuracy across acute, subacute, and chronic SDH categories.
JLK-SDH received FDA 510(k) clearance in the U.S. on March 3, 2025, for its AI-powered subdural hemorrhage detection tool. JLK, Inc. states that it manages all data, including medical information, in compliance with HIPAA and SOC 2 security controls, applying encryption, access controls, and audit logging.
While AI tools like JLK-SDH show promise, general limitations of AI in neuroimaging can include concerns around data privacy, security, and the need for continuous research to refine algorithms. JLK has conducted clinical trials on both Asian and Western patients to ensure its AI is trained on broad, unbiased datasets.
JLK-SDH is integrated into a mobile app called SNAPPY (now FASTRO) that alerts physicians when SDH is detected on non-contrast CT scans, aiming to reduce diagnosis time. While specific alternatives to JLK-SDH are not detailed, other AI solutions for stroke and hemorrhage detection exist in the market.

Related Tools

syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
Neurophet AQUA AD Plus
Neurophet
Neurology AI
Neurophet AQUA AD Plus is an AI-powered brain imaging analysis software that supports the diagnosis, treatment guidance, and monitoring of Alzheimer's disease by analyzing MRI and PET scans.
myosmart trial kit
Otto Bock Healthcare Products GmbH
Neurology AI
The Ottobock MyoSmart Trial Kit assists clinicians in assessing and fitting advanced neurorehabilitation prosthetic and orthotic solutions.
connectgrip. (560X27-1)
Otto Bock Healthcare Products GmbH
Neurology AI
Otto Bock Healthcare Products GmbH offers advanced prosthetic and orthotic solutions, with 'connectgrip' (560X27-1) likely being a component designed for secure and functional connection within these systems, potentially incorporating intelligent features for enhanced user control.
myosmart.cuff (757M20-2)
Otto Bock Healthcare Products GmbH
Lab & Diagnostics
The myosmart.cuff is a medical device by Otto Bock Healthcare Products GmbH designed for objective measurement of muscle tone, primarily for use in neurological rehabilitation.
myosmart. (13E522)
Otto Bock Healthcare Products GmbH
Neurology AI
myosmart.

See all Neurology AI tools →

More from JLK

JBS-LVO
JLK
Neurology AI
JBS-LVO by JLK Inc.
JLK-ICH
JLK, Inc.
Neurology AI
Medihub Prostate
JLK
Oncology AI

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-08 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.